These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15474428)

  • 21. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive local recurrence increased after radiation therapy for ductal carcinoma in situ.
    Guerra LE; Smith RM; Kaminski A; Lagios MD; Silverstein MJ
    Am J Surg; 2008 Oct; 196(4):552-5. PubMed ID: 18809062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
    Shen J; Hunt KK; Mirza NQ; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Ross MI; Ames FC; Feig BW; Singletary SE; Cristofanilli M; Meric-Bernstam F
    Cancer; 2005 Aug; 104(3):479-90. PubMed ID: 15968686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local recurrences after conservative treatment of ductal carcinoma-in-situ of the breast without radiotherapy: the effect of age.
    Schouten van der Velden AP; Peeters PH; Koot VC; Hennipman A
    Ann Surg Oncol; 2006 Jul; 13(7):990-8. PubMed ID: 16788762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study.
    Giardina C; Serio G; Lepore G; Lettini T; Dalena AM; Pennella A; D'Eredità G; Valente T; Ricco R
    J Exp Clin Cancer Res; 2003 Jun; 22(2):279-88. PubMed ID: 12866579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
    Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
    Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
    Subramaniam MM; Chan JY; Soong R; Ito K; Ito Y; Yeoh KG; Salto-Tellez M; Putti TC
    Breast Cancer Res Treat; 2009 Jan; 113(1):113-21. PubMed ID: 18256927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
    Jiveliouk I; Corn B; Inbar M; Merimsky O
    Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
    Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
    Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.
    Tunon-de-Lara C; André G; Macgrogan G; Dilhuydy JM; Bussières JE; Debled M; Mauriac L; Brouste V; de Mascarel I; Avril A
    Ann Surg Oncol; 2011 May; 18(5):1372-9. PubMed ID: 21108045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
    Collins LC; Tamimi RM; Baer HJ; Connolly JL; Colditz GA; Schnitt SJ
    Cancer; 2005 May; 103(9):1778-84. PubMed ID: 15770688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of ductal carcinoma in situ of the breast.
    Lagios MD
    J Cell Biochem Suppl; 1993; 17G():49-52. PubMed ID: 8007709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
    Fisher ER; Land SR; Fisher B; Mamounas E; Gilarski L; Wolmark N
    Cancer; 2004 Jan; 100(2):238-44. PubMed ID: 14716756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
    Jayasinghe UW; Bilous AM; Boyages J
    Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy.
    Jobsen JJ; Van Der Palen J; Ong F; Meerwaldt JH
    Acta Oncol; 2007; 46(2):172-80. PubMed ID: 17453365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.